EOSINOPHILIC GRANULOMATOUS VASCULITIS

Clinical trials for EOSINOPHILIC GRANULOMATOUS VASCULITIS explained in plain language.

Never miss a new study

Get alerted when new EOSINOPHILIC GRANULOMATOUS VASCULITIS trials appear

Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOUS VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Head-to-Head trial tests new shot for rare, debilitating blood vessel disease

Disease control Ongoing

This study compares two injectable medications, benralizumab and mepolizumab, for treating a rare autoimmune disease called EGPA. It involves 140 adults whose EGPA keeps coming back or hasn't responded well to standard steroid treatments. The main goal is to see which drug is bet…

Matched conditions: EOSINOPHILIC GRANULOMATOUS VASCULITIS

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

EOSINOPHILIC GRANULOMATOUS VASCULITIS

Get alerted when new EOSINOPHILIC GRANULOMATOUS VASCULITIS trials appear

Head-to-Head trial tests new shot for rare, debilitating blood vessel disease